Universal Ibogaine Statistics
Total Valuation
IBOGF has a market cap or net worth of 6.64 million. The enterprise value is 8.31 million.
| Market Cap | 6.64M |
| Enterprise Value | 8.31M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 308.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +51.81% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 280.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.07 |
| PB Ratio | 28.12 |
| P/TBV Ratio | 28.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.29 |
| EV / Sales | 6.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.20 |
Financial Position
The company has a current ratio of 0.49, with a Debt / Equity ratio of 7.60.
| Current Ratio | 0.49 |
| Quick Ratio | 0.47 |
| Debt / Equity | 7.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.42 |
| Interest Coverage | -7.16 |
Financial Efficiency
Return on equity (ROE) is -216.76% and return on invested capital (ROIC) is -18.56%.
| Return on Equity (ROE) | -216.76% |
| Return on Assets (ROA) | -14.80% |
| Return on Invested Capital (ROIC) | -18.56% |
| Return on Capital Employed (ROCE) | -39.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +97.30% in the last 52 weeks. The beta is 6.92, so IBOGF's price volatility has been higher than the market average.
| Beta (5Y) | 6.92 |
| 52-Week Price Change | +97.30% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 42.25 |
| Average Volume (20 Days) | 100,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBOGF had revenue of 1.31 million and -1.57 million in losses. Loss per share was -0.01.
| Revenue | 1.31M |
| Gross Profit | 130,863 |
| Operating Income | -768,439 |
| Pretax Income | -1.57M |
| Net Income | -1.57M |
| EBITDA | -528,372 |
| EBIT | -768,439 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 189,360 in cash and 1.80 million in debt, giving a net cash position of -1.61 million.
| Cash & Cash Equivalents | 189,360 |
| Total Debt | 1.80M |
| Net Cash | -1.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 236,211 |
| Book Value Per Share | 0.00 |
| Working Capital | -341,423 |
Cash Flow
In the last 12 months, operating cash flow was -714,192 and capital expenditures -27,640, giving a free cash flow of -741,832.
| Operating Cash Flow | -714,192 |
| Capital Expenditures | -27,640 |
| Free Cash Flow | -741,832 |
| FCF Per Share | n/a |
Margins
Gross margin is 9.99%, with operating and profit margins of -58.66% and -119.86%.
| Gross Margin | 9.99% |
| Operating Margin | -58.66% |
| Pretax Margin | -119.86% |
| Profit Margin | -119.86% |
| EBITDA Margin | -40.33% |
| EBIT Margin | -58.66% |
| FCF Margin | n/a |
Dividends & Yields
IBOGF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -51.81% |
| Shareholder Yield | -51.81% |
| Earnings Yield | -23.64% |
| FCF Yield | -11.17% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IBOGF has an Altman Z-Score of -10.16. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.16 |
| Piotroski F-Score | n/a |